1. Home
  2. Clinical Topics
  3. New High-Dose Influenza Vaccine for Seniors
Clinical TopicsHealthcare & TechnologyImmune/Lymphatic SystemInfection PreventionInfectious DiseasesWeb Exclusives

New High-Dose Influenza Vaccine for Seniors

A news release from Sanofi Pasteur includes information on the first shipment of a new high-dose influenza vaccine for adults ages 65 years of age and older can be accessed at the link below. Fluzone High-Dose vaccine is payable benefit under Medicare Part B. Recently, the Centers for Medicare and Medicaid Services (CMS) updated its various pricing files to include Fluzone High-Dose vaccine in the “July 2010 AWP NDC – HCPCS Crosswalk File” for Medicare Part B Drugs. The AWP file identifies physician administered vaccines and drugs that are payable services under Medicare Part B. Please click here to view the CMS AWP File.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.


Recent Posts